Mandate

Vinge advises Irisity AB (publ)

November 10, 2018 Capital Markets and Public M&A

Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.

The subscription price of SEK 17.50 has been determined through a so called accelerated book building process. Irisity will receive approximately MSEK 25 as a result of the issue. The issue proceeds will be used, among other things, for Irisity’s development and accelerated growth by strengthening the organization through the recruitment of personnel, which can occur both through new employment and acquisition of companies with the requisite competence and thereby increasing the company’s financial flexibility and freedom of action for continued growth creation. SEB acted as financial adviser.

Vinge’s team primarily consisted of responsible partner Anders Strid, Frida Bergqvist, Wibeke Sorling and corporate assistant Camilla Andersson.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025